Axel Bolte - 01 May 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Axel Bolte
Issuer symbol
INZY
Transactions as of
01 May 2023
Net transactions value
$0
Form type
4
Filing time
03 May 2023, 08:40:07 UTC
Previous filing
04 Apr 2023
Next filing
15 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +100,000 $0.000000 100,000 01 May 2023 Common Stock 100,000 $5.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 1, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from June 1, 2023 through May 1, 2025, provided Mr. Bolte is providing services to the Company on such dates.